Weiqiang Zhao

13.0k total citations · 2 hit papers
119 papers, 4.1k citations indexed

About

Weiqiang Zhao is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Weiqiang Zhao has authored 119 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 34 papers in Molecular Biology and 32 papers in Genetics. Recurrent topics in Weiqiang Zhao's work include Chronic Lymphocytic Leukemia Research (27 papers), Lymphoma Diagnosis and Treatment (20 papers) and Acute Myeloid Leukemia Research (17 papers). Weiqiang Zhao is often cited by papers focused on Chronic Lymphocytic Leukemia Research (27 papers), Lymphoma Diagnosis and Treatment (20 papers) and Acute Myeloid Leukemia Research (17 papers). Weiqiang Zhao collaborates with scholars based in United States, China and United Kingdom. Weiqiang Zhao's co-authors include John C. Byrd, Nyla A. Heerema, Amy J. Johnson, Kristie A. Blum, Jan A. Burger, William G. Wierda, Steven Coutré, Susan O’Brien, Richard R. Furman and Jeffrey A. Jones and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Weiqiang Zhao

113 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib

2015 484 citations John C. Byrd, Richard R. Furman et al. profile →
E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group

2017 317 citations Shanthi Marur, Shuli Li et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Weiqiang Zhao

Since Specialization

Citations

This map shows the geographic impact of Weiqiang Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiqiang Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiqiang Zhao more than expected).

Fields of papers citing papers by Weiqiang Zhao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiqiang Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiqiang Zhao. The network helps show where Weiqiang Zhao may publish in the future.

Co-authorship network of co-authors of Weiqiang Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Weiqiang Zhao. A scholar is included among the top collaborators of Weiqiang Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiqiang Zhao. Weiqiang Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Incidence, Clinicopathologic Features, and Follow-Up Results of human epidermal growth factor receptor-2–Ultralow Breast Carcinoma 2025 ·Modern Pathology ·Yan Hu, Dan Jones, Weiqiang Zhao, Gary Tozbikian, Anil V. Parwani, Zaibo Li	2
2	Composite fixed-length ordered features with index-of-max transformation for high-performing and secure palmprint template protection 2024 ·SHILAP Revista de lepidopterología ·Zhicheng Cao, Weiqiang Zhao, Heng Zhao, Liaojun Pang	0
3	Epitope prime editing shields hematopoietic cells from CD123 immunotherapy for acute myeloid leukemia 2024 ·Cell stem cell ·(unknown), Guohua Cao, Weiqiang Zhao, (unknown), Pan Gao, Yizhou Zhang, Xuebin Wang, Hou-Yuan Qiu, (unknown), (unknown), (unknown), Hao Yin, Ying Zhang	9
4	Incidence, Clinicopathologic Features, HER2 Fluorescence In Situ Hybridization Profile, and Oncotype DX Results of Human Epidermal Growth Factor Receptor 2-Low Breast Cancers: Experience From a Single Academic Center 2023 ·Modern Pathology ·Yan Hu, Dan Jones, Weiqiang Zhao, Gary Tozbikian, Robert Wesolowski, Anil V. Parwani, Zaibo Li	11
5	Characteristics and outcomes of patients with CLL and CDKN2A/B deletion by fluorescence in situ hybridization 2023 ·Blood Advances ·(unknown), (unknown), Adam S. Kittai, Seema A. Bhat, Michael R. Grever, Kerry A. Rogers, Weiqiang Zhao, Dan Jones, John C. Byrd, Matthew R. Avenarius, Nyla A. Heerema, Jennifer A. Woyach, Cecelia Miller	4
6	Inhibition of polo-like kinase 1 (PLK1) facilitates reactivation of gamma-herpesviruses and their elimination 2021 ·PLoS Pathogens ·(unknown), Dawei Zhou, Guillaume Fiches, (unknown), Xuefeng Liu, Qin Ma, Weiqiang Zhao, Jian Zhu, Netty Santoso	10
7	Ibrutinib Treatment for First-Line and Relapsed/Refractory Chronic Lymphocytic Leukemia: Final Analysis of the Pivotal Phase Ib/II PCYC-1102 Study 2020 ·Clinical Cancer Research ·John C. Byrd, Richard R. Furman, Steven Coutré, Ian W. Flinn, Jan A. Burger, Kristie A. Blum, Jeff P. Sharman, William G. Wierda, Weiqiang Zhao, Nyla A. Heerema, Ying Luan, Emily A. Liu, James P. Dean, Susan O’Brien	126
8	Activation of the RAS pathway through uncommon BRAF mutations in mucinous pancreatic cysts without KRAS mutation 2020 ·Modern Pathology ·Rongqin Ren, Somashekar G. Krishna, (unknown), Wendy L. Frankel, Rulong Shen, Weiqiang Zhao, Matthew R. Avenarius, (unknown), (unknown), Dan Jones	22
9	Unexpected expression of mismatch repair protein is more commonly seen with pathogenic missense than with other mutations in Lynch syndrome 2020 ·Human Pathology ·(unknown), Heather Hampel, Rachel Pearlman, Dan Jones, Weiqiang Zhao, (unknown), Deborah A. Knight, Wendy L. Frankel	19
10	Double somatic mismatch repair gene pathogenic variants as common as Lynch syndrome among endometrial cancer patients 2020 ·Gynecologic Oncology ·Heather Hampel, Rachel Pearlman, Albert de la Chapelle, Colin C. Pritchard, Weiqiang Zhao, Dan Jones, Ahmet Yılmaz, Wei Chen, Wendy L. Frankel, Adrian A. Suarez, Casey Cosgrove, Floor Backes, Larry J. Copeland, Jeffrey M. Fowler, David M. O’Malley, Ritu Salani, Joseph P. McElroy, Peter P. Stanich, Paul J. Goodfellow, David E. Cohn	26
11	Successive minutia‐free mosaicking for small‐sized fingerprint recognition 2019 ·IET Image Processing ·Jiong Chen, Heng Zhao, Zhicheng Cao, Weiqiang Zhao, Liaojun Pang	7
12	Extended Treatment with Single-Agent Ibrutinib at the 420 mg Dose Leads to Durable Responses in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 2017 ·Clinical Cancer Research ·Steven Coutré, Richard R. Furman, Ian W. Flinn, Jan A. Burger, Kristie A. Blum, Jeff P. Sharman, Jeffrey A. Jones, William G. Wierda, Weiqiang Zhao, Nyla A. Heerema, Amy J. Johnson, (unknown), Cathy Zhou, Elizabeth Bilotti, Danelle F. James, John C. Byrd, Susan O’Brien	47
13	E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group breakdown → 2017 ·Journal of Clinical Oncology ·Shanthi Marur, Shuli Li, Anthony J. Cmelak, Maura L. Gillison, Weiqiang Zhao, Robert L. Ferris, William H. Westra, Jill Gilbert, Julie E. Bauman, Lynne I. Wagner, David R. Trevarthen, (unknown), Barbara A. Murphy, Nishant Agrawal, A. Dimitrios Colevas, Christine H. Chung, Barbara Burtness	317
14	Metastatic Squamous Cell Carcinoma Component from an Adenosquamous Carcinoma of the Lung with Identical Epidermal Growth Factor Receptor Mutations 2015 ·SHILAP Revista de lepidopterología ·Jarred Burkart, Konstantin Shilo, Weiqiang Zhao, (unknown), (unknown), Gregory A. Otterson	11
15	Upfront molecular testing in patients with advanced gastro-esophageal cancer: Is it time yet? 2015 ·Oncotarget ·Sameh Mikhail, Kristen K. Ciombor, Anne M. Noonan, Christina Wu, Richard M. Goldberg, Weiqiang Zhao, Lai Wei, (unknown), (unknown), Cynthia Timmers, Tanios Bekaii‐Saab	5
16	Primary Meningeal Pleomorphic Xanthoastrocytoma With Anaplastic Features: A Report of 2 Cases, One WithBRAF^V600EMutation and Clinical Response to theBRAFInhibitor Dabrafenib 2015 ·Journal of Neuropathology & Experimental Neurology ·(unknown), Christopher R. Pierson, (unknown), Kristin Huntoon, Oleksandr N. Kryvenko, (unknown), Weiqiang Zhao, Jack Rock, Mario Ammirati, Vinay K. Puduvalli, Norman L. Lehman	28
17	Impact of Pre-Analytical Variables on Cancer Targeted Gene Sequencing Efficiency 2015 ·PLoS ONE ·Luiz H. Araujo, Cynthia Timmers, Konstantin Shilo, Weiqiang Zhao, Jianying Zhang, Lianbo Yu, Thanemozhi G. Natarajan, (unknown), Ayse Selen Yilmaz, Tom Liu, Joseph M. Amann, José Roberto Lapa e Silva, Carlos Gil Ferreira, David P. Carbone	12
18	DDB2 Suppresses Tumorigenicity by Limiting the Cancer Stem Cell Population in Ovarian Cancer 2014 ·Molecular Cancer Research ·Chunhua Han, Ran Zhao, Xingluo Liu, Amit Kumar Srivastava, Li Gong, Hsiaoyin Mao, Meihua Qu, Weiqiang Zhao, Jianhua Yu, Qi‐En Wang	43
19	Genomic Characterization of Non-Small Cell Lung Cancer in African Americans by Targeted Massively Parallel Sequencing 2014 ·International Journal of Radiation OncologyBiologyPhysics ·Luiz H. Araujo, Cynthia Timmers, (unknown), (unknown), Thanemozhi G. Natarajan, Jibin Zhang, Konstantin Shilo, Weiqiang Zhao, Joseph M. Amann, Philip E. Lammers, David P. Carbone	3
20	DNA Damage-Binding Complex Recruits HDAC1 to Repress Bcl-2 Transcription in Human Ovarian Cancer Cells 2013 ·Molecular Cancer Research ·Ran Zhao, Chunhua Han, (unknown), (unknown), Weiqiang Zhao, Jianhua Yu, Karuppaiyah Selvendiran, Xingluo Liu, Altaf A. Wani, Qi‐En Wang	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact